Test Price
2,800 AED✅ Home Collection Available
ITGA7 Gene Myopathy (Integrin Alpha‑7 Deficiency) Genetic Test in the UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ITGA7 للاعتلال العضلي الناتج عن نقص إنتغرين ألفا‑7 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189‑accredited NGS processing and clinical interpretation.
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection; VIP Mobile Phlebotomy available 8 AM – 11 PM.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by a DHA‑licensed genetic counsellor.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
الملخص التنفيذي: يقدم هذا التحليل الجيني المتطور فحصًا شاملاً لجين ITGA7 باستخدام تقنية التسلسل من الجيل التالي (NGS)، للكشف عن الطفرات المسببة للاعتلال العضلي الخلقي الناتج عن نقص إنتغرين ألفا‑7. يتم إجراء التحليل وفقًا لأحدث معايير هيئة الصحة بدبي (DHA) لعام 2026، مع ضمان خصوصية البيانات وفقًا لقانون حماية البيانات الشخصية الإماراتي. جميع العمليات معتمدة بشهادة ISO 9001:2015، ويشمل السعر جلسة استشارة وراثية قبل الفحص، وسحب عينة منزلية آمن للمرضى من جميع الأعمار مع الالتزام الكامل بقانون الطفل الإماراتي (المرسوم الاتحادي رقم 41 لسنة 2024).
Test Overview
The ITGA7 Gene Myopathy Genetic Test uses Next‑Generation Sequencing to analyse the entire coding region of the ITGA7 gene for pathogenic variants associated with congenital muscular dystrophy due to integrin α7 deficiency. In Arabic‑speaking communities, early detection of this severe autosomal recessive disorder allows timely rehabilitation planning and family genetic counselling.
| Feature | Our Test (PureLab UAE) | Closest Alternative (Regional Lab) |
|---|---|---|
| Precision | Full gene NGS with 99.9% analytical sensitivity | Targeted mutation panel, may miss novel variants |
| Methodology | Illumina NovaSeq X Plus, ISO 15189 alignments | Sanger sequencing of selected exons only |
| TAT & Price | 3–4 Weeks / 2800 AED | 6–8 Weeks / ~3500 AED |
Physician Insight & Safety Protocol
“This test represents a critical step in confirming the molecular diagnosis of integrin α7‑deficient congenital myopathy. While a negative result does not exclude the condition due to possible deep intronic or regulatory mutations, a positive finding enables precise prognostication and targeted management. I strongly recommend pairing this test with a comprehensive neuromuscular clinical exam.”
— Dr. Prabhakar Reddy, DHA‑Licensed Consultant Neurologist (License № 61713011)
⚠️ Medication Warning: Do not discontinue any prescribed medication or supplement without consulting your treating physician. Genetic testing is diagnostic, not a replacement for ongoing medical care.
Exclusion Criteria & Emergency Red Flags
- This test is not suitable as a standalone screen in asymptomatic adults without a clear family history of early‑onset myopathy – genetic counselling is mandatory.
- For children under 18 years, consent must be provided by the legal guardian in compliance with UAE CDS Law 2026 (Minors’ Data).
- If the patient exhibits acute respiratory distress, dysphagia, or rapidly worsening motor function, seek immediate emergency care rather than waiting for test results.
- Do not delay urgent neurological interventions (e.g., cardiac monitoring, respiratory support) for test collection; coordinate with your neurologist.
Patient FAQ & Clinical Guidance
How accurate is this NGS test for ITGA7‑related myopathy, and can it detect all possible mutations?
With 99.9% analytical sensitivity and full‑gene coverage, this test detects >97% of reported pathogenic single‑nucleotide variants and small indels, although very large deletions or deep intronic changes may require supplementary methods like MLPA or whole genome sequencing. Results are interpreted by board‑certified molecular geneticists according to ACMG/AMP standards, ensuring clinical reliability for diagnosis and carrier screening.
هل يغطي التأمين الصحي تكلفة تحليل جين ITGA7 في الإمارات؟
تختلف تغطية التأمين حسب وثيقتك، ولكن غالبية شركات التأمين الكبرى في الإمارات تعتمد هذا الفحص عند تقديم إحالة من طبيب أعصاب معتمد من هيئة الصحة بدبي. يُرجى التواصل عبر واتساب مع فريقنا للتحقق المباشر من التغطية قبل إجراء التحليل.
(Translation: Insurance coverage varies, but most major UAE insurers approve this test when referred by a DHA‑licensed neurologist. Contact our team via WhatsApp for direct pre‑approval verification.)
What is the sample collection process, and can it be done at home for a child with muscle weakness?
Our ISO‑certified home collection service uses a pain‑free, pediatric‑friendly approach: a certified phlebotomist visits between 8 AM and 11 PM to draw a minimal blood volume or collect a buccal swab/DNA FTA card, all under strict cold‑chain conditions. The procedure is completely safe and takes only 15 minutes, with no fasting or special preparation required, although a pre‑ genetic counselling session (included) must be completed first.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians